Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Exploring Agios' Mitapivat’s Role in Managing Transfusion-Dependent and Non–Transfusion-Dependent Thalassemia

Ticker(s): AGIO

Who's the expert?

Institution: Cornell University

Professor of Clinical Pediatrics and Vice Chair of Clinical Research at Weill Cornell Medicine.
Leads the New York Comprehensive Thalassemia Center at Weill Cornell Medicine, providing care for over 250 patients with thalassemia and related red blood cell disorders.
Conducts NIH-funded research on iron overload and hemoglobinopathies, contributing to advancements in treatment for thalassemia and sickle cell disease.

Interview Goal

This call will explore how mitapivat impacts hemoglobin levels and reduces transfusion needs in both transfusion-dependent and non-transfusion-dependent thalassemia patients, providing insights into its potential benefits across different disease severities.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.